Beyond Biopsy Maximising the Value of ctDNA Technology Today Within the Biopsy Model of Precision Medicine

Time: 9:00 am
day: Day Two Morning


• Untapped potential that new ctDNA-dependent technologies present, and the Guardant’s 3.0 suite
• What makes Guardant, Guardant and why that matters
• Simplification and shared innovation with ctDNA and why that will accelerate global impact of medicines on patients’ lives